Skip to main content
logo
Neurizon Therapeutics Limited (ASX:NUZ)
Australia flag Australia · Delayed Price · Currency is AUD
0.0780
0.00 (0.00%)
Sep 11, 2026, 11:11 AM AEST

Neurizon Therapeutics Financials Overview

Millions AUD. Fiscal year is Jul - Jun.

Revenue & Profits
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Revenue
17.5917.591.540.840.874.51
Revenue Growth
194.10%1043.54%82.70%-3.66%-80.63%23.33%
Gross Profit
17.5917.591.540.840.874.2
Operating Income
-10.17-10.17-16.94-5.82-1.65-1.62
Net Income
-10.72-10.72-16.59-7.67-6.21-1.71
Earnings Per Share
-0.02-0.02-0.03-0.02-0.02-0.01
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Cash & Investments
12.7112.714.1810.732.722.42
Total Debt
3.313.31--1.051.39
Net Cash (Debt)
9.49.44.1810.731.671.03
Net Cash Growth
48.61%124.85%-61.03%541.45%61.66%-40.75%
Net Cash Per Share
0.020.020.010.030.010.00

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Operating Cash Flow
-15.07-15.07-14.29-5.17-1.56-1.33
Capital Expenditures
-0.01-0.01-0--0.03-0.04
Free Cash Flow
-15.08-15.08-14.29-5.17-1.6-1.38
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingJun '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
Gross Margin
100.00%100.00%100.00%100.00%100.00%93.03%
Operating Margin
-57.83%-57.83%-1101.34%-691.08%-188.64%-35.92%
Pretax Margin
-60.98%-60.98%-1079.02%-1057.36%-179.95%-37.87%
Profit Margin
-60.98%-60.98%-1079.02%-911.61%-710.99%-37.88%
FCF Margin
-85.77%-85.77%-929.50%-614.05%-183.02%-30.50%

Valuation
Chart
Fiscal YearCurrentFY 2026FY 2025FY 2024FY 2023FY 2022
Period EndingSep '26 Jun '26 Jun '25 Jun '24 Jun '23 Jun '22
PS Ratio
3.442.6151.22103.1029.834.92